Burcon to Commence Trading on the NASDAQ Global Market

Vancouver (ots/PRNewswire) -

Burcon NutraScience Corporation ("Burcon" or the "Company") is
pleased to announce that its common shares have been authorized to
commence trading on The NASDAQ Global Market under the symbol "BUR"
on October 27, 2011.

To acknowledge this achievement, Burcon is scheduled to ring The
NASDAQ Opening Bell on October 27th, 2011. The NASDAQ Opening Bell
Ceremony will take place from 9:15 am to 9:30 am ET. A live webcast
of The NASDAQ Opening Bell Ceremony will be available at:
http://www.nasdaq.com/about/marketsitetowervideo.asx or
http://social.nasdaqomx.com

Burcon's common shares will continue to be listed on the Toronto
Stock Exchange under the symbol "BU".

Burcon is a world leader in the innovation and development of
highly functional sustainable plant protein ingredients.

"Having our shares trade on NASDAQ is a natural progression for
our company," said Johann F. Tergesen, president and COO of Burcon,
adding "The NASDAQ Stock Market is the de facto global market for
innovation and technology companies, making it ideally suited for
Burcon which is focused on innovation in the agri-food technology
sector. It is also a natural evolution for us as U.S.-based Archer
Daniels Midland Company has just recently launched our lead protein
product, CLARISOY(TM), in the United States. The U.S. investment
community recognizes that food security and food technology are
important investment themes. Our NASDAQ listing will help us to raise
awareness of Burcon's timely opportunity in the vital food and
agri-food technology sectors and make our shares more accessible to
U.S. investors."

Burcon's business strategy is focused on developing a sound
patent portfolio that broadly protects our core protein extraction
and protein application inventions. In general, we have sought to
protect our processing technologies, the functional applications of
our novel plant proteins as they may be used in food and beverage
products, and also to protect the signature characteristics of the
proteins themselves.

About Burcon NutraScience

Burcon is a leader in nutrition, health and wellness in the field
of functional, renewable plant proteins. Since 1999, Burcon has
developed a portfolio of composition, application, and process
patents originating from our core protein extraction and purification
technology. We are developing Puratein(R) and Supertein(TM) canola
protein isolates with unique functional and nutritional attributes,
and CLARISOY(R), a revolutionary soy protein isolate which is 100%
soluble and completely transparent in low pH solutions. Our team of
highly specialized scientists and engineers work from our private
research facility to develop and optimize environmentally sound
technologies. To-date, our patent portfolio consists of 173 issued
patents in various countries, including 30 issued U.S. patents, and
in excess of 300 additional pending patent applications, 71 of which
are U.S. patent applications.

CLARISOY(TM) is a trademark of Archer-Daniels-Midland Company.

ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
President and Chief Operating Officer

The TSX has not reviewed and does not accept responsibility for
the adequacy of the content of the information contained herein. This
press release contains forward-looking statements that involve risks
and uncertainties. These forward-looking statements relate to, among
other things, the schedule for the commencement of trading on NASDAQ,
and other expectations, intentions and plans contained in this press
release that are not historical fact. Our expectations regarding the
prospect for future success depend upon our ability to develop and
sell products, which we do not produce today and cannot be sold
without further research and development or reliance on our
development partner. When used in this press release, the words
"goal", "intend", "believes" and "potential" and similar expressions,
generally identify forward-looking statements. These statements
reflect our current expectations. They are subject to a number of
risks and uncertainties.

For further information:
Jade Cheng, Chief Financial Officer
Burcon NutraScience Corporation
+1(604)733-0896 / +1(888)408-7960 toll-free
jcheng@burcon.ca http://www.burcon.ca

ots Originaltext: Burcon NutraScience Corporation
Im Internet recherchierbar: http://www.presseportal.de

Contact:
.